STAT+: Up and Down the Ladder: The latest comings and goings
Stat News • 4/24/2026
Summary
The article titled "STAT+: Up and Down the Ladder" reports on the latest comings and goings in the pharmaceutical industry, including new hires, departures, promotions, and transfers. It provides updates on personnel changes within the sector.
Advertisement
Lindy Score Breakdown (V4.2)
2h
Age
1
Sources
from cluster
4
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier94% (0.5^4/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy
Stat News • 2 days ago
STAT+: CMS, FDA team up to fast-track reimbursement for breakthrough devices
Stat News • 1 day ago
STAT+: AMA calls for regulatory crackdown on chatbots, wellness AI
Stat News • 1 day ago
STAT+: With successful trials, Roche takes its MS drug to regulators, but safety questions loom
Stat News • 2 days ago
STAT+: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy
Stat News • 1 day ago
STAT+: Gene therapy trial for deafness adds evidence to drug’s efficacy
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about Medicare’s obesity drug pilot, an experimental Roche MS drug, and more
Stat News • 2 days ago
STAT+: At AACR, talk of Chinese biotech, oncology’s comms issue, and more
Stat News • 2 days ago
STAT+: Key GOP senators push back on Trump’s plan to cut NIH, reorganize HHS
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about cheap telehealth visits, pharma withholding meds in Europe, and more
Stat News • 1 day ago